Janux Therapeutics News

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(19.99%),Peter Kolchinsky(19.99%), etc.

Mar 6 18:55 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.

Mar 6 16:23 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D.(17.1%),Tighe Reardon(10.4%), etc.

Mar 4 20:11 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Avalon Ventures XI, L.P.

Mar 4 19:36 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gujrathi Sheila

Mar 4 16:47 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CAPPS VICKIE L

Mar 4 16:37 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.

Feb 14 17:58 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(6.8%),Citadel Advisors Holdings LP(6.8%), etc.

Feb 14 17:06 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(9.9%),BVF Inc.(9.9%), etc.

Feb 14 09:47 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Campbell, Ph.D.(5.3%)

Feb 9 16:38 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.117%),Abigail P. Johnson(10.117%)

Feb 9 09:20 ET

Janux Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bregua Corporation(8.3%)

Feb 1 16:19 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Winter Charles M.

Jan 3 00:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Robinson Byron

Jan 3 00:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell David Alan

Jan 3 00:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer DiRaimondo Thomas

Jan 3 00:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Tighe

Jan 3 00:00 ET

Janux Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meyer Andrew Hollman

Jan 3 00:00 ET

Janux Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer DiRaimondo Thomas

Jan 3 00:00 ET

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D. (“Lichter”)(21.2%),Tighe Reardon (“Reardon”)(12.5%), etc.

Nov 15, 2023 18:22 ET